2023. Economic Evaluation of FDA-Approved Small Molecule Protein Kinase Inhibitors in Oncology and Non-Oncology Indications in the United States. Indo-American Journal of Life Sciences and Biotechnology. 20, 1 (Feb. 2023), 15–46.